Abstract:Objective: We aimed to report a summary of clinical outcomes following preimplantation genetic testing for monogenic conditions, by performing a systematic review of published literature on clinical pregnancy and live birth rates following preimplantation genetic testing due to a monogenic indication. Additionally, we aimed to undertake a subgroup analysis of clinical outcomes of concurrent monogenic and aneuploidy screening. Data sources: Three electronic databases (MEDLINE, EMBASE, and PubMed) were searched from inception to May 2024. Study eligibility criteria: Quantitative data audits, observational studies, and case series reporting clinical outcomes for individuals undergoing preimplantation genetic testing for a monogenic indication were included. Only studies using blastocyst biopsies with polymerase chain reaction-based or genome-wide haplotyping methods for molecular analysis were eligible to reflect current laboratory practice. Methods: Quality assessment was performed following data extraction using an adaptation of the Joanna Briggs critical appraisal tool for case series. Results were extracted, and pooled mean clinical pregnancy rates and birth rates were calculated with 95% confidence intervals (95% CI). We compared outcomes between those with and without concurrent preimplantation genetic testing for aneuploidy. Results: Our search identified 1372 publications; 51 were eligible for inclusion. Pooled data on 5305 cycles and 5229 embryo transfers yielded 1806 clinical pregnancies and 1577 births. This translated to clinical pregnancy and birth rates of 34.0% [95% CI: 32.8%-35.3%] and 29.7% [95% CI: 28.5%-31.0%] per cycle and 24.8% [95% CI: 23.6%-26.0%] and 21.7% [95% CI: 20.8%-23.1%] per embryo transfer. In studies with concurrent aneuploidy screening, clinical pregnancy and birth rates were 43.3% [95% CI: 40.2%-46.5%] and 37.6% [95% CI: 34.6%-40.8%] per cycle and 37.0% [95% CI: 33.9%-40.3%] and 31.8% [95% CI: 28.8%-35.0%] per embryo transfer. Studies without aneuploidy screening reported clinical pregnancy and birth rates of 32.5% [95% CI: 31.0%-34.1%] and 28.1% [95% CI: 26.6%-29.7%] per cycle and 21.2% [95% CI: 19.8%-22.6%] and 18.6% [95% CI: 17.3%-20.0%] per embryo transfer. Conclusion: This systematic review reveals promising clinical outcome figures for this indication group. Additionally, synthesizing the published scientific literature on clinical outcomes from preimplantation genetic testing for monogenic conditions provides a rigorous, noncommercial evidence base for counseling.

"Comparison of Outcomes Between Intracytoplasmic Sperm Injection and In Vitro Fertilization with Pre-implantation Genetic Testing for Aneuploidy, Analysis of SART CORS Data".

ICSI Does Not Improve Live Birth Rates but Yields Higher Cancellation Rates Than Conventional IVF in Unexplained Infertility

Aneuploidy Rates and Clinical Pregnancy Outcomes after Preimplantation Genetic Testing for Aneuploidy Using the Progestin-Primed Ovarian Stimulation Protocol or the Gonadotropin-Releasing Hormone Antagonist Protocol

Are Testicular Sperms Superior to Ejaculated Sperms in Couples with Previous ART Failure Due to High Rate of Fragmented Embryos? A Retrospective Cohort Study

Intracytoplasmic Sperm Injection Versus Conventional In-Vitro Fertilisation for Couples with Infertility with Non-Severe Male Factor: a Multicentre, Open-Label, Randomised Controlled Trial

#244 : Reproductive Outcomes of Conventional in Vitro Fertilization and Intracytoplasmic Sperm Injection in Patients with Non-Severe Male Infertility Across Poor and Different Suboptimal Ovarian Response Categories

Reproductive Outcomes of Conventional In Vitro Fertilization and Intracytoplasmic Sperm Injection in Patients with Non-Severe Male Infertility Across Poor and Different Sub-Optimal Ovarian Response Categories: A Cohort Study Based on 30,352 Fresh Cycles from 2009–2019

Comparison of Preimplantation Genetic Testing for Aneuploidy Versus Intracytoplasmic Sperm Injection in Severe Male Infertility

Reproductive outcomes of conventional in vitro fertilization and intracytoplasmic sperm injection in patients with non-severe male infertility across poor and different sub-optimal ovarian response categories: a cohort study based on 30352 fresh cycles from 2009-2019

The impact of intracytoplasmic sperm injection versus conventional in vitro fertilization on the reproductive outcomes of couples with non-male factor infertility and frozen-thawed embryo transfer cycles

Comparative Study on Risk for Birth Defects among Infants after in Vitro Fertilization and Intracytoplasmic Sperm Injection

Preimplantation Genetic Testing for Aneuploidy Improves Clinical Outcomes in Patients with Repeated Implantation Failure

CONVENTIONAL IVF AND ICSI IN PATIENTS WITH NON-SEVERE MALE INFERTILITY ACROSS POOR AND DIFFERENT SUB-OPTIMAL OVARIAN RESPONSE PATIENTS.

Fertilization and Pregnancy Outcome with Intracytoplasmic Sperm Injection Using Ejaculate Sperm, Surgically Retrieved Sperm and Frozen-thawed Sperm

A comparison of pregnancy outcomes and congenital malformations in offspring between patients undergoing intracytoplasmic sperm injection and conventional in vitro fertilization: A retrospective cohort study

Feasibility of preimplantation genetic testing for aneuploidy on frozen-thawed embryos following conventional IVF insemination

Clinical Analysis of Intracytoplasmic Sperm Injection in Patients with Previous Fertilization Failure after Conventional IVF

The impact of preimplantation genetic testing for aneuploidy on prenatal screening

Higher Abnormal Fertilization, Higher Cleavage Rate, and Higher Arrested Embryos Rate Were Found in Conventional Ivf Than in Intracytoplasmic Sperm Injection

Impact of aneuploidy on reproductive success in young infertile women: prospective analysis

Clinical outcomes following preimplantation genetic testing for monogenic conditions: a systematic review of observational studies